ABTAbbott Laboratories
Who owns ABT
2,899 institutions reported holding ABT for 2026Q2, together 78% of the company, fewer than the 3,028 a quarter earlier.
Institutions reporting a position · as of 2026Q2 · down from 3,028 the quarter before
- Shares held by institutions
- 1.37B
Shares held by institutions · 78% of the company · long US equity positions only, as reported on Form 13F
- Reported value
- $124.3B
Reported value · at Jun 30, 2026 prices, not today's
- Top 5 holders
- 29%
Top 5 holders · of the whole company, between five filers
Details›
- Reporting quarter2026-06-30
- 2026Q2
- Quarters on record
- 53
- New positions
- 201
- Positions exited
- 328
- Added to
- 933
- Reduced
- 1,256
- Top 10 holdersof the company
- 38%
- Shares sold shortsettled Sep 30, 2026
- 13.6M
- Short interestof shares outstanding
- 0.78%
- Days to coverat the average daily volume
- 1.5
- Change in the short positionsince the Sep 15, 2026 count
- −32%
| Quarter | Filers | Shares | Reported value |
|---|---|---|---|
| 2026Q2 | 2,899 | 1.37B | $124.3B |
| 2026Q1 | 3,028 | 1.36B | $140.2B |
| 2025Q4 | 3,202 | 1.42B | $212.1B |
| 2025Q3 | 3,111 | 1.35B | $180.4B |
| 2025Q2 | 3,118 | 1.37B | $306.7B |
| 2025Q1 | 3,117 | 1.36B | $180.8B |
| 2024Q4 | 3,006 | 1.34B | $151.9B |
| 2024Q3 | 2,860 | 1.30B | $148.3B |
| 2024Q2 | 2,829 | 1.31B | $136.2B |
| 2024Q1 | 2,856 | 1.30B | $147.8B |
| 2023Q4 | 2,840 | 1.30B | $142.9B |
| 2023Q3 | 2,637 | 1.29B | $124.6B |
| 2023Q2 | 2,695 | 1.29B | $140.9B |
| 2023Q1 | 2,663 | 1.29B | $131.0B |
| 2022Q4 | 2,720 | 1.29B | $142.3B |
| 2022Q3 | 2,580 | 1.29B | $125.1B |
| Holder | Shares | % of company | Value |
|---|---|---|---|
| VANGUARD GROUP INC | 181.5M | 10% | $16.5B |
| BlackRock Inc. | 152.6M | 8.7% | $13.8B |
| STATE STREET CORP | 80.9M | 4.6% | $7.34B |
| Charles Schwab Trust Co | 59.7M | 3.4% | $5.41B |
| GEODE CAPITAL MANAGEMENT LLC | 39.2M | 2.2% | $3.54B |
| Capital Research Global Investors | 36.9M | 2.1% | $3.35B |
| Capital International Investors | 34.7M | 2.0% | $3.15B |
| MORGAN STANLEY | 26.6M | 1.5% | $2.41B |
| NORGES BANK | 23.4M | 1.3% | $2.12B |
| PRICE T ROWE ASSOCIATES INC /MD/ | 22.8M | 1.3% | $2.07B |
| Settlement | Shares short | Of shares outstanding | Days to cover |
|---|---|---|---|
| Sep 30, 2026 | 13.6M | 0.78% | 1.5 |
| Sep 15, 2026 | 19.9M | 1.1% | 2.6 |
| Aug 31, 2026 | 22.1M | 1.3% | 2.7 |
| Aug 14, 2026 | 20.4M | 1.2% | 2.9 |
| Jul 31, 2026 | 22.6M | 1.3% | 1.7 |
| Jul 15, 2026 | 24.8M | 1.4% | 2.1 |
| Jun 30, 2026 | 23.4M | 1.3% | 1.5 |
| Jun 15, 2026 | 22.0M | 1.3% | 1.8 |
| May 29, 2026 | 22.0M | 1.3% | 1.9 |
| May 15, 2026 | 23.2M | 1.3% | 1.7 |
| Apr 30, 2026 | 22.5M | 1.3% | 1.5 |
| Apr 15, 2026 | 21.7M | 1.2% | 2.3 |
SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold. The short position is FINRA's consolidated count for each twice-monthly settlement date, as a share of shares outstanding.
Medical Devices
The closest names by size in the same industry